Why the study?
Does platelet function testing predict or prevent stent thrombosis and bleeding in acute coronary syndrome patients undergoing percutaneous coronary intervention?
Does platelet function testing predict or prevent stent thrombosis and bleeding in acute coronary syndrome patients undergoing percutaneous coronary intervention?
This expert opinion paper provides clinical recommendations on the use of platelet function testing for predicting stent thrombosis and bleeding in ACS patients undergoing PCI.
Answers are grounded in this paper and cite their sources.
Provides recommendations on controversial platelet function testing in ACS-PCI; extends evidence synthesis for selective clinical and trial use.
The role of platelet function testing in acute coronary syndrome patients undergoing percutaneous coronary intervention remains controversial despite the fact that high platelet reactivity is an independent predictor of stent thrombosis and emerging evidence suggests also a link between low platelet reactivity and bleeding. In this expert opinion paper, the Study Group on Biomarkers in Cardiology of the Acute Cardiovascular Care Association and the Working Group on Thrombosis of the European Society of Cardiology aim to provide an overview of current evidence in this area and recommendations for practicing clinicians.
No takes yet. Share an insight, caveat, or question.
Collet et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: